Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
Switch Symbol:
Net Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-54.84M
↑ 24% above average
Average (8y)
$-72.34M
Historical baseline
Range
High:$-13.21M
Low:$-125.58M
CAGR
+19.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-54.84M | +11.9% |
| 2023 | $-62.26M | +34.2% |
| 2022 | $-94.66M | +22.9% |
| 2021 | $-122.72M | -34.7% |
| 2020 | $-91.14M | +27.4% |
| 2019 | $-125.58M | -109.0% |
| 2018 | $-60.08M | -126.3% |
| 2017 | $-26.55M | -101.0% |
| 2016 | $-13.21M | - |